Back to COGT
NORTHERN TRUST CORP COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
21
Latest value
$487K
Q3 2026
Peak value
$55.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $729K |
| Q4 2025 | $1.2M |
| Q4 2025 | $1M |
| Q4 2025 | $39.2M |
| Q4 2025 | $463K |
| Q4 2025 | $12K |
| Q1 2026 | $771K |
| Q1 2026 | $1.3M |
| Q1 2026 | $1.1M |
| Q1 2026 | $44.2M |
| Q1 2026 | $582K |
| Q2 2026 | $1M |
| Q2 2026 | $1.9M |
| Q2 2026 | $1.2M |
| Q2 2026 | $55.7M |
| Q2 2026 | $577K |
| Q3 2026 | $792K |
| Q3 2026 | $1.7M |
| Q3 2026 | $892K |
| Q3 2026 | $45.9M |
| Q3 2026 | $487K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $487K | 15.2K | — | — |
| Q3 2026 | $45.9M | 1.43M | — | — |
| Q3 2026 | $892K | 27.9K | — | — |
| Q3 2026 | $1.7M | 54.1K | — | — |
| Q3 2026 | $792K | 24.7K | — | — |
| Q2 2026 | $577K | 14.9K | — | — |
| Q2 2026 | $55.7M | 1.44M | — | — |
| Q2 2026 | $1.2M | 30.2K | — | — |
| Q2 2026 | $1.9M | 48.7K | — | — |
| Q2 2026 | $1M | 25.9K | — | — |
| Q1 2026 | $582K | 15.1K | — | — |
| Q1 2026 | $44.2M | 1.15M | — | — |
| Q1 2026 | $1.1M | 29.0K | — | — |
| Q1 2026 | $1.3M | 33.5K | — | — |
| Q1 2026 | $771K | 20.0K | — | — |
| Q4 2025 | $12K | 334 | — | — |
| Q4 2025 | $463K | 13.0K | — | — |
| Q4 2025 | $39.2M | 1.10M | — | — |
| Q4 2025 | $1M | 29.1K | — | — |
| Q4 2025 | $1.2M | 33.5K | — | — |
| Q4 2025 | $729K | 20.5K | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M